Skip to main content
CATX logo

Perspective Therapeutics, Inc.

CATXNYSEAMERICANHealthcareMedical Devices

$1.21Today:- (-)1Y −21.53%

As of Oct 26, 2026 close

Market cap
$145.99M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.96$6.16
Volume (live)
-
Avg. volume (3M)
2.57M

Perspective Therapeutics (CATX) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Perspective Therapeutics had return on equity of -41.6% (up from -42.8%), debt-to-equity of 0.02 (up from 0.01), a current ratio of 5.17 (down from 12.68) and return on assets of -23.3% (down from -19.0%). A current ratio of 5.17 means current assets exceed current liabilities.

Perspective Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 2025Dec 2024Dec 2023Jun 2022Jun 2021
Valuation Ratios
Forward P/E21.5021.5021.5021.50-
P/S Ratio231.25148.2878.65-11.23
P/B Ratio0.990.741.500.721.68
Price/Tangible Book1.220.90147.820.721.68
Enterprise Value Ratios
EV/Revenue38.02-68.42-4.86
Profitability & Returns
Return on Equity (ROE)-41.65%-42.82%-57.70%-9.79%-9.26%
Return on Assets (ROA)-23.34%-19.02%-32.81%-5.95%-5.43%
Return on Capital Employed (ROCE)-47.70%-20.70%-49.80%-10.30%-5.00%
Leverage & Solvency Ratios
Debt/Equity0.020.010.030.010.01
Liquidity Ratios
Current Ratio5.1712.681.0726.1837.37
Quick Ratio5.0812.530.6725.3836.58
Efficiency Ratios
Asset Turnover0.000.010.02-0.25
Inventory Turnover----6.07
Yield & Distribution Ratios
Earnings Yield-50.44%-36.77%-41.23%-16.57%-3.00%
FCF Yield-46.58%-33.72%-33.68%-18.17%-2.85%
Buyback Yield-14.57%-140.71%-88.38%-36.73%-53.61%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Perspective Therapeutics Financial Ratios

What is Perspective Therapeutics's return on equity?

Perspective Therapeutics's return on equity (ROE) was -41.6% for fiscal 2025 (period ended Dec 31, 2025). It was -42.8% a year earlier.

What is Perspective Therapeutics's debt-to-equity ratio?

Perspective Therapeutics's debt-to-equity ratio was 0.02 for fiscal 2025 (period ended Dec 31, 2025). It was 0.01 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition